The Hindu Business Line : Wockhardt, Sinclair sign pact

Drug-maker Wockhardt Ltd has entered into a 10- year in-licensing agreement with the UK's Sinclair Pharma plc to market dermatology and dental products in India. The agreement also envisages that Wockhardt manufacture the formulation in India from bulk imported from Sinclair Pharma, a note from Wockhardt said.

The Indian dermatology market is estimated at Rs 1,782 crore. Wockhardt is also in talks with Sinclair for contract manufacturing signed products for their European markets and to bring in to India the next phase of dermatology products from the Sinclair stable.

The agreement will help Wockhardt consolidate its position in the two segments which includes drugs like Papulex (an innovative formulation for acne and a leading product in the segment in France), Atopiclair (non-steroidal cream for atopic dermatitis), Aloclair (patented gel for mouth ulcer), Decapinol range (patented formulation for the treatment of Gingivitis and plaque). - Our Bureau

More Stories on : Alliances & Joint Ventures | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Rasi Seeds' R&D centre

Promoters hike holding in Hindalco

RNRL places MoU on gas sharing before court

Elecon Engg bags Rs 52-cr orders

Tata Steel gets award for TQM

Siemens sets up new arm for rail transportation sector

Magna to set up unit to make car window systems

Glaxo’s drive against filariasis

USFDA nod for Strides facility

Wockhardt, Sinclair sign pact

Tolins to launch LCV tyres

Wartsila hopes to ride tough times on strong order book

Auto rickshaws to form 10% of TVS Motor’s revenues

Cairn yet to get ‘right of use’ for Rajasthan pipeline